There's an important lesson to be learned by the career of the Parris Campbell, and it should influence the Cowboys' 2025 NFL ...

In the mood for monsters and mythological heroes? Look no further than Rick Riordan's fun, fast-paced Percy Jackson series, which follows the adventures of young demigod (half mortal, half Greek god) ...

IF YOUR MAIN FITNESS goal is to add mass and chisel out your figure, then the thought of building "lean muscle" likely sounds rather appealing. After all, why would you dedicate hours in the gym ...

Muscle rigidity is very common, and it can be uncomfortable. You can have stiff and tense muscles due to various causes—such as sitting or sleeping in the wrong position, or it can be the result of a ...

On Wednesday, Clone Robotics released video footage of its Protoclone humanoid robot, a full-body machine that uses synthetic muscles to create unsettlingly human-like movements. In the video ...

Clone’s Myofiber technology uses artificial muscles to move the skeleton by attaching them to precise bone points, like animals. In December, Clone entered the competitive humanoid robotics ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

In adolescents and young adults, they could be connected to a body image disorder that exhibits a pathological focus on muscle development and leanness, according to new research. “The use of 6 ...

Veru, Eli Lilly, Regeneron, among leaders in muscle-preserving drug development FDA approval criteria for these drugs remains unclear Doctors, analysts focused on health benefits beyond weight ...

The Lightning Thief: The Percy Jackson Musical has announced new company members for its Other Palace run. The musical adaptation of Rick Riordan’s bestselling The Lightning Thief first premiered ...

Approval would upend two decades of failure for myostatin pathway inhibitors, a class of drugs that grows skeletal muscle. Beyond the first regulatory decision for apitegromab, companies are ...